Real-time enrollment status for this alpha and beta thalassemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:27 PM UTC
| NCT Number | NCT03937817 |
| Recruiting Status | Recruiting |
| Condition | Alpha and Beta Thalassemia |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT03937817 is currently recruiting participants. This clinical trial study for alpha and beta thalassemia is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03937817 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03937817 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.